1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

C5 is Pleased to Announce its 2nd European Pharmaceutical Regulatory Law Forum

C5’s European Pharma Regulatory Law forum is a comprehensive industry conference designed to update you on the most recent European regulatory developments

 
PRLog - Jul. 25, 2011 - C5’s European Pharma Regulatory Law forum is a comprehensive industry conference designed to update you on the most recent European regulatory developments affecting the pharma industry and provide you with effective strategies for compliance and risk management.

NEW in Brussels!

The event will offer you the opportunity to network with your peers, key industry regulators and expert lawyers, whilst learning about the most recent and significant industry developments to keep you up-to-date and competitive!
Gain Practical Insights on…:

•Interpreting the Pharmacovigilance rules and the impact on reporting obligations
•The inclusion of environmental aspects into the EU legislation on Good Manufacturing Practice (GMP)
•Obtaining and maintaining an effective pricing and reimbursement structure
•The interaction between competition law and pharma regulatory requirements
•The do’s and don’ts in multi-jurisdiction clinical trials: where are we and where are we going?
•Adopting an effective product labelling model to combat anti-counterfeitinG
•The rise in social media: balancing information to patients and advertising to ensure compliance
•The approach to labelling negotiations and product liability litigation in Europe and the US
•The current US approval process in light of recent regulatory and legislative developments
•Successfully obtaining SPCs and extensions of Regulatory Data Protection: Extending your market exclusivity

Our outstanding speaker faculty includes:

•Dr. Joachim Schwerin, Head of Competition Team, DG Enterprise and Industry, European Commission (Belgium)
•Dr. Janice Soreth, Deputy Director, Europe Office, US Food & Drug Administration (UK) (provisionally confirmed)
•Dr. Alexander Natz, Head of Brussels Office, Federation of Pharmaceutical Industry (Belgium)
•Charlotte Unger, Scientific Director Environment, Medical Products Agency (Sweden)
•Ilaria Passarani, Senior Health Policy Officer, The European Consumers' Organisation (Belgium)
•John Chave, Secretary General, Pharmaceutical Group of the European Union (Germany)

Visit us online at http://www.c5-online.com/pharmaforum

--- End ---

Click to Share

Contact Email:
***@americanconference.com Email Verified
Source:C5 Communications
Country:United States
Industry:Biotech, Legal, Health
Tags:pharmaceutical, biotech, regulatory, fcpa, UK Bribert Act
Shortcut:prlog.org/11599068
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share